Loading clinical trials...
Loading clinical trials...
Immunoglobulin Therapy for Patients With Idiopathic Cardiomyopathy and Endomyocardial Parvovirus B19 Persistence - a Prospective, Double-blind, Randomized, Placebo-controlled Clinical Trial
Conditions
Interventions
Intravenous Immunoglobulins
plasma volume expander
Locations
1
Netherlands
AZM
Maastricht, Netherlands
Start Date
November 1, 2009
Primary Completion Date
June 1, 2018
Completion Date
June 1, 2018
Last Updated
August 29, 2018
NCT00326690
NCT00005228
NCT00005227
Lead Sponsor
Prothya Biosolutions
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions